Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-038043

Director disposed of 1,000,000 shares (other)

  • Director acquired 5,075 shares (other)
  • Director acquired 3,253 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
NELSEN ROBERT Director 2021-03-22 Other disposition −500,000 10,168,749 I
NELSEN ROBERT Director 2021-05-12 Other disposition −500,000 9,668,749 I
NELSEN ROBERT Director 2021-03-22 Other acquisition +2,538 4,568 D
NELSEN ROBERT Director 2021-05-12 Other acquisition +2,537 7,105 D
NELSEN ROBERT Director 2021-06-01 Option exercise +3,253 10,358 D
Derivatives
NELSEN ROBERT Director 2021-06-01 Option exercise · Restricted Stock Units −3,253 0 D
Loading xslF345X03/doc4.xml…